FUSE earnings analysis
What we found in FUSE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Fusemachines reported a weak operating quarter: Q2 revenue declined 12% year over year to $1.794 million, gross margin compressed to 53.7% from 59.3%, and operating loss widened to $2.690 million from $0.852 million. EPS improved to $(0.10) from $(0.52), but the improvement was driven largely by reduced fair-value and other non-operating losses rather than operating leverage. Liquidity is critical, with $0.368 million of cash, $(3.511) million of six-month operating cash outflow, a $16.75 million working-capital deficit, and substantial doubt regarding going-concern status. The company has pursued additional financing, but the $2.500 million discounted convertible-note financing, warrant overhang, Nasdaq deficiencies, and ineffective controls materially elevate risk.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue declined on fewer clients
- Q2 revenue declined 12% to $1.794 million from $2.034 million, primarily reflecting a net decrease in total clients. Six-month revenue fell 8% to $3.673 million from $3.987 million.
- Gross margin compressed
- Q2 gross profit decreased to $0.963 million from $1.206 million, compressing gross margin to approximately 53.7% from 59.3%. Six-month gross profit was $1.911 million versus $2.295 million.
- EPS loss narrowed year over year
- Q2 EPS improved to $(0.10) from $(0.52), while net loss narrowed to $2.849 million from $3.786 million. The improvement was helped by substantially lower non-operating fair-value losses, including a prior-year $2.860 million loss.
- Legacy convertible debt largely eliminated
- The company eliminated substantially all convertible notes through prior conversions and had only a $0.300 million related-party loan payable outstanding at June 30, 2026. Q2 interest expense declined to $0.052 million from $0.073 million.
- Potential $20 million equity facility
- The company signed a Common Stock Purchase Agreement providing up to $20.0 million of potential equity financing over 36 months. No proceeds had been received as of the filing date and the related S-1 registration statement was not yet effective.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Severe liquidity and going-concern risk
- The filing states that substantial doubt exists about continuing as a going concern within one year. Cash was only $0.368 million at June 30, 2026, six-month operating cash flow was $(3.511) million, and net working capital deficit was approximately $16.75 million.
- New discounted notes and dilution
- The August 2 financing added $2.500 million of original-principal senior unsecured convertible notes due February 12, 2027 in exchange for $2.050 million of proceeds, plus warrants for 2,050,000 shares. The notes convert at $4.20 per share and could require immediate repayment upon specified registration defaults.
- Floating-price warrants increase dilution
- The amended Shortfall Warrants cover up to 2,108,070 shares and now have a floating exercise price equal to the greater of the Forward Purchase Agreement termination price or $0.85, replacing the prior fixed $10.00 price. The amendment could increase dilution and derivative-liability volatility if the share price declines.
- Multiple Nasdaq listing deficiencies
- Nasdaq issued a July 24, 2026 notice that the company was below the $15.0 million MVPHS requirement for 30 consecutive business days, giving it until January 20, 2027 to regain compliance. The company also has until September 23, 2026 to regain compliance with the $50.0 million MVLS requirement.
- Internal controls remain ineffective
- Management reported that disclosure controls were not yet effective as of June 30, 2026, and that remediation efforts for previously identified material weaknesses had not yet been tested. The filing lists 8 control deficiencies, including inadequate segregation of duties and insufficient U.S. GAAP expertise.
- Vendor payment default exposure
- The company defaulted on two professional-service settlement installments totaling $0.052 million. The provider may pursue the full undiscounted outstanding balance of $1.032 million, although no default notice had been issued as of the filing date.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.1
- Gross margin
- 53.7%
- Operating margin
- -149.9%
- Segment
- Single operating segment: data engineering, artificial intelligence consulting, and technical services; Q2 2026 revenue was $1.794 million versus $2.034 million in Q2 2025, down $0.240 million or 12%.
- Segment
- AI Solutions (Products and Services): Q2 2026 revenue was $1.784 million versus $1.913 million, down $0.129 million; six-month revenue was $3.656 million versus $3.866 million, down $0.210 million.
- Segment
- AI Education Services: Q2 2026 revenue was $0.010 million versus $0.121 million, down $0.111 million; six-month revenue was $0.017 million versus $0.121 million, down $0.104 million.
What they said about what is next.
No numeric revenue or EPS guidance was provided. Management expects to access additional equity or debt capital as needed over the next year, but stated that existing cash and potential financing may not be sufficient to meet working capital and capital expenditure requirements for at least the next twelve months.
The filing reads worse than the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing FUSE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever